.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Baxter
QuintilesIMS
Deloitte
Fish and Richardson
Mallinckrodt
AstraZeneca
Moodys
Merck
Boehringer Ingelheim

Generated: July 28, 2017

DrugPatentWatch Database Preview

Tentative Approvals for: Amneal Pharms

« Back to Dashboard
Applicant Generic Name NDA Strength Dosage Form
Amneal Pharms
saxagliptin
2059415MGTABLET;ORAL
Amneal Pharms
saxagliptin;metformin hydrochloride
2059425MG;500MGTABLET, EXTENDED RELEASE;ORAL
Amneal Pharms Co
lurasidone hydrochloride
20800220MGTABLET;ORAL
Amneal Pharms
lisdexamfetamine dimesylate
20283020MGCAPSULE;ORAL
Amneal Pharms
fesoterodine fumarate
2050024MGTABLET, FOR SUSPENSION;ORAL
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Colorcon
QuintilesIMS
Express Scripts
Daiichi Sankyo
McKesson
Citi
Cerilliant
Fuji
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot